Oryzon Genomics SA
MAD:ORY

Watchlist Manager
Oryzon Genomics SA Logo
Oryzon Genomics SA
MAD:ORY
Watchlist
Price: 1.534 EUR -0.9% Market Closed
Market Cap: 97.8m EUR
Have any thoughts about
Oryzon Genomics SA?
Write Note

Wall Street
Price Targets

ORY Price Targets Summary
Oryzon Genomics SA

Wall Street analysts forecast ORY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ORY is 6.222 EUR with a low forecast of 2.323 EUR and a high forecast of 12.6 EUR.

Lowest
Price Target
2.323 EUR
51% Upside
Average
Price Target
6.222 EUR
306% Upside
Highest
Price Target
12.6 EUR
721% Upside
Oryzon Genomics SA Competitors:
Price Targets
SVE
Synthaverse SA
56% Upside
BCRX
BioCryst Pharmaceuticals Inc
100% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
17% Upside
1167
Jacobio Pharmaceuticals Group Co Ltd
204% Upside
SKYE
Skye Bioscience Inc
580% Upside
VYGR
Voyager Therapeutics Inc
203% Upside
QURE
Uniqure NV
14% Upside
ADAG
Adagene Inc
350% Upside

Revenue
Forecast

Revenue Estimate
Oryzon Genomics SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Oryzon Genomics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-47%
Average Miss

Net Income
Forecast

Net Income Estimate
Oryzon Genomics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ORY's stock price target?
Price Target
6.222 EUR

According to Wall Street analysts, the average 1-year price target for ORY is 6.222 EUR with a low forecast of 2.323 EUR and a high forecast of 12.6 EUR.

Back to Top